Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes
Open Access
- 21 March 2017
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 5, 22-30
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Molecular Determinants of Vectofusin-1 and Its Derivatives for the Enhancement of Lentivirally Mediated Gene Transfer into Hematopoietic Stem/Progenitor CellsJournal of Biological Chemistry, 2016
- Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approachesLeukemia, 2014
- Concurrent Measures of Fusion and Transduction Efficiency of Primary CD34+ Cells with Human Immunodeficiency Virus 1-Based Lentiviral Vectors Reveal Different Effects of Transduction EnhancersHuman Gene Therapy Methods, 2014
- Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantationImmunological Reviews, 2013
- RD2-MolPack- Chim3, a Packaging Cell Line for Stable Production of Lentiviral Vectors for Anti-HIV Gene TherapyHuman Gene Therapy Methods, 2013
- Infectivity enhancement of different HIV-1-based lentiviral pseudotypes in presence of the cationic amphipathic peptide LAH4-L1Journal of Virological Methods, 2013
- Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II studyThe Lancet Oncology, 2009
- Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cellsGene Therapy, 2004
- Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primatesBlood, 2002
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997